These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24206091)

  • 1. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
    Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
    Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
    Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
    Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
    Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
    Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
    de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
    BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
    Bennett M; Schechter GP
    Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ
    Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
    Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
    Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
    Fallah J; Olszewski AJ
    Hematology; 2019 Dec; 24(1):378-386. PubMed ID: 30885066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
    Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
    World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.
    Pata G; Damiani E; Bartoli M; Solari S; Anastasia A; Pagani C; Tucci A; Ragni F
    Leuk Lymphoma; 2016; 57(6):1467-70. PubMed ID: 26373930
    [No Abstract]   [Full Text] [Related]  

  • 15. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
    Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
    Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
    Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
    Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Splenic marginal zone lymphoma].
    Mohamed S
    Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.